National Centers for Cryo-electron Tomography (cryoET) (R24 -Clinical Trial Not Allowed)
- Not stated
- Not stated
- Feb 5, 2026
Official announcement on Grants.gov · opens the funder's page. Always confirm dates there.
Or read the full text and all 7 review criteria here, free with an account. Create free account
Summary
Technical advances in single particle cryoelectron microscopy (cryoEM) have enabled generation of reliable atomic models of complete and fully functional macromolecular complexes…
Related NIH announcements
NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed)
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)
The full announcement, free with an account
- The full announcement text, not just the first two sentences
- All 7 review criteria reviewers score this against, extracted from this announcement
On Plus, $39 a month
- The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
- Funded precedents: what similar NIH projects received, from the award records in NIH RePORTER
- A Reviewer Scorecard of your draft against these criteria
More from National Institutes of Health
NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
$500k
Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
Related by subject
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
$150k
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
$300k